N/A
N=90
Acceptance-based Group Intervention for Binge Eating
Binge-Eating Disorder
Bottom Line
View on ClinicalTrials.gov: NCT01757847 ↗Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcome: Primary: Change From Baseline in Binge Eating Scale (BES) at 4 Weeks, 3 Months and 6 Months — 17.38; 15.45; 10.52; 13.52 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Acceptance and Commitment Therapy (ACT) (Behavioral); Brief MOVE-II control group intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Binge Eating Scale (BES) at 4 Weeks, 3 Months and 6 Months |
17.38; 15.45; 10.52; 13.52; 10.47; 11.90 | — |
| SECONDARY Change From Baseline in The Obesity-related Well Being Scale (ORWELL-97) at 4 Weeks, 3 Months, and 6 Months |
50.17; 49.47; 41.86; 46.02; 41.07; 38.79 | — |
Summary
This study proposes to compare a brief Acceptance and Commitment Therapy (ACT) group intervention to an active control group in a sample of 154 overweight or obese binge eating Veterans who have completed the VA's national behavioral weight management program (MOVE!). This study anticipates that the ACT intervention will reduce binge eating and distress while improving functioning and maintenance of weight loss.
Eligibility Criteria
Inclusion Criteria
- Diagnosis of overweight or obesity (i.e., BMI > 25 kg/m2), as verified by a study physician after a medical evaluation and examination of medical records;
- Attendance of at least 60% of weight loss sessions of the MOVE! program (i.e., 5 of 8 sessions).
- At least 18 years old
Exclusion Criteria
- Serious or unstable medical or psychiatric illness (i.e., current unmanaged psychosis, manic episode, anorexia nervosa, bulimia nervosa, or substance abuse within the past year) or psychosocial instability (e.g., homelessness) that could compromise study participation;
- Conditions in which exercise or weight loss will be detrimental to one's health (e.g., pregnancy);
- Active suicidal ideation or history of suicide attempt within 5 years;
- Pharmacotherapy for obesity (e.g., Orlistat or Meridia) or bariatric surgery within the past 6 months or planning to start such treatments in the next 6 months;
- Current participation in group or individual psychotherapy for weight management or binge eating;
- Previous treatment with ACT;
- Unwillingness to agree not to change professionally delivered mood treatments and psychotherapy (e.g., begin new therapy or group; discontinue a treatment; increase the dose of medication) for the duration of 4-week study treatment period unless medically necessary.
Data sourced from ClinicalTrials.gov (NCT01757847). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.